Montserrat Plana
Research group
- AIDS and HIV infection Accredited researcher (R3A)
Featured publications
-
In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
Authors:Reference: Viruses-Basel 2021. -
Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV
Authors:Reference: Journal Of Controlled Release 2021. -
High rates of long-term progression in HIV-1-positive elite controllers
Authors:Reference: Journal Of The International Aids Society 2021. -
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
Authors:Reference: Scientific Reports 2020. -
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection
Authors:Reference: Aids 2020. -
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection
Authors:Reference: Biochemical Pharmacology 2020. -
A classifier to predict viral control after antiretroviral treatment interruption in chronic HIV-1 infected patients
Authors:Reference: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2020. -
Local barrier dysfunction identified by confocal laser endomicroscopy predicts bacterial translocation in HIV infection
Authors:Reference: Aids 2020. -
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B
Authors:Reference: Vaccines 2019. -
Therapeutic vaccine in chronically Hiv-1-infected patients: A randomized, double-blind, placebocontrolled phase IIa trial with HTI-Trimix
Authors:Reference: Vaccines 2019.
Featured Projects
-
Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)
Principal investigator: Felipe GarcíaFunder: Instituto de Salud Carlos IIICode: RD16/0025/0002Duration: 01/01/2017 - 31/12/2022 -
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)
Code: CE_H2020-SC1_16abr1sDuration: 02/01/2017 - 31/12/2021 -
FluNanoAir Design of Human Influenza vaccines using multifunctional micelles harnessing innate immunity
Principal investigator: Montserrat Plana IP from Partner 2 (FCRB / IDIBAPS)Duration: 01/01/2017 - 31/12/2019 -
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
Principal investigator: Felipe Garcia Alcaide, Giuseppe Pantaleo Co-IPCode: CE_H2020-PHCRTD-15Duration: 02/01/2016 - 31/12/2020 -
DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS
Duration: 01/01/2016 - 01/01/2018